Marchex's third quarter delivered the profitability inflection it had promised, but not the growth. Adjusted earnings of $0.04 per share matched the $0.04 consensus. They fell short of the $0.05 Earnings Whisper number, a 20.0% miss against the whisper. Revenue of $15.97 million missed the $16.24 million consensus by 1.6% and landed at the bottom of management's own $16.0 to $16.5 million range. On the Earnings Whispers normalized basis, earnings grew 300.0% year over year and revenue grew 38.7%. The release, however, presents prior-year results 'as adjusted' for the Archenia combination. On that basis, revenue rose only about 5%, from $15.2 million to $16.0 million. That gap is the central tension. The margin story is real, but the combined top line is expanding far more slowly than the 15% to 20% combined run-rate growth management framed on its fourth-quarter 2025 and first-quarter 2026 calls.

The quality of the earnings improvement deserves a closer look, because it came almost entirely from cost cuts rather than revenue leverage. GAAP net income swung to $1.3 million, or $0.03 per share, from a $1.3 million loss a year ago. Adjusted EBITDA jumped to $2.4 million from $0.5 million, or $2.6 million (16% margin) before reorganization and acquisition costs. Management called this a run rate above $10 million annualized and its best in over a decade. Operating expenses beyond cost of revenue fell to $6.7 million from $9.3 million:

• Sales and marketing dropped about $700,000.
• Product development dropped about $700,000.
• G&A dropped about $1.2 million.
• Stock compensation and depreciation also declined.

Meanwhile, gross margin slipped to 51% from 54% on revenue mix and paid-pilot costs. Adjusted EBITDA of $2.4 million sat within the $2.3 to $2.5 million guide but slightly below the 'combined ~$2.5M or more' framing from the first-quarter call.

On the call, management leaned on commercial proof points rather than numbers:

• **AI Voice Agent conversion.** The advertising/media customer cited as a pilot last quarter converted to a commercial AI Voice Agent deployment. It is expected to add more than $200,000 in annualized revenue in 2027 on a roughly $400,000 base.
• **Automotive OEM approval.** A major automotive OEM approved Engage for Service for its dealer portal, making the product eligible for co-op funding after a 75-dealership pilot. That is potentially the more scalable development.
• **Pipeline.** Management said several seven-figure pipeline deals have progressed since the second quarter, with specific large deals targeted for year-end. Paid AI Voice Agent pilots are under discussion with several large enterprises.
• **Leadership.** Former Archenia CEO Travis Fairchild was named President to drive commercialization.

Demand signals improved, but bears have legitimate ammunition in what went missing. The top-100 customer adoption metrics shared on prior calls were not updated. The 'rule of 30-40' framing disappeared. The initial 2027 outlook promised on the second-quarter call was deferred to March 2027.

Fourth-quarter guidance calls for revenue of $15.0 million or more and adjusted EBITDA of $2.3 to $2.5 million. Management attributes the sequential revenue decline to typical seasonality and says pipeline timing could help it outperform. Even so, the guide implies year-over-year growth against a fourth quarter 2025 that ran in the low-$14 million range. Management says 2027 will be an 'increasing growth year' and that EBITDA can scale above the $10 million run rate despite planned sales and product investment. That investment is itself a risk to the newly established margin.

The balance sheet also changed meaningfully with the acquisition. Related-party obligations and contingent earn-outs now total roughly $16 million, including about $7.4 million classified as current. That compares with $8.7 million in cash, which did tick up from $8.2 million at the end of the second quarter. Stockholders' equity roughly halved from year-end to $14.7 million.

Investor sentiment swung sharply into the report, moving from -0.43 after the August release to +0.61. Investors moved from clearly negative to solidly positive expectations, which may explain why matching consensus while missing the whisper registers as a disappointment. Price action tells a less enthusiastic story:

• Shares sat at $1.30 before the report, down 24.9% from the $1.73 open following the August results.
• They were 17.1% below the $1.57 200-day moving average.
• The quarter included both a 52-week high of $2.00 in late August and a 52-week low of $1.15 in mid-September, leaving the stock just 13% above that low.

The Earnings Whispers price, sequential-growth and AVWAP readings remain negative, with only momentum positive.

The bottom line is that Marchex proved it can be profitable as a combined company, largely by cutting costs, but it has not yet proved the Archenia deal can produce the accelerating growth that was sold to investors. Roughly 5% combined growth, a low-end revenue print, softer gross margin and a deferred 2027 outlook leave the growth thesis resting on pipeline conversion and the OEM channel. Investors will not get hard numbers on either until March.